IN8bio Inc.
Organization details
- Legal name
- IN8bio Inc.
- Former names
- Incysus Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- INAB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001740279
- EIN
- 82-5462585
Board of directors
-
Alan S. Roemer · DirectorSince 2023
-
Corinne Epperly · DirectorSince 2023
-
Emily Fairbairn · DirectorSince 2023
-
Jeremy R. Graff · DirectorSince 2023
-
Luba Greenwood · DirectorSince 2023
-
Peter C. Brandt · DirectorSince 2023
-
Travis Whitfill · DirectorSince 2023
-
William Tai-Wei Ho · Director · CEOSince 2023
Chief executives
Director election results
Annual meeting of May 8, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.8%
-
90.3%
-
96.0%
Board connections
3 of this board's directors also sit on 3 other boards. 2 are in the same sector.
-
Azitra Inc Same sectorvia Travis Whitfill
- via Emily Fairbairn
-
Traws Pharma Inc. Same sectorvia Luba Greenwood
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Emily Fairbairn Director | Gift | −724,637 | — | — |
| Dec 22, 2025 | Rochlin Kate Officer (Chief Operating Officer) | Grant or award | +7,247 | $1.38 | $10,001 |
| Dec 22, 2025 | McCall Patrick Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +7,247 | $1.38 | $10,001 |
| Dec 22, 2025 | William Tai-Wei Ho Director, Officer (PRESIDENT AND CEO), 10% owner | Grant or award | +36,232 | $1.38 | $50,000 |
| Dec 22, 2025 | Alan S. Roemer Director | Grant or award | +36,232 | $1.38 | $50,000 |
| Dec 22, 2025 | Peter C. Brandt Director | Grant or award | +72,464 | $1.38 | $100,000 |
| Dec 22, 2025 | Emily Fairbairn Director | Grant or award | +724,637 | $1.38 | $999,999 |
| Apr 30, 2025 | Rochlin Kate Officer (Chief Operating Officer) | Option exercise | +12,295 | $0.18 | $2,213 |
| Apr 30, 2025 | McCall Patrick Officer (CHIEF FINANCIAL OFFICER) | Option exercise | +15,000 | $0.18 | $2,700 |
| Apr 30, 2025 | Alan S. Roemer Director | Option exercise | +102,459 | $0.18 | $18,443 |
| Apr 30, 2025 | Peter C. Brandt Director | Option exercise | +81,967 | $0.18 | $14,754 |
| Apr 30, 2025 | Alan S. Roemer Director | Option exercise | +11,000 | $0.18 | $1,980 |
| Apr 30, 2025 | Peter C. Brandt Director | Option exercise | +81,967 | $0.18 | $14,754 |
| Oct 4, 2024 | Rochlin Kate Officer (Chief Operating Officer) | Grant or award | +25,316 | — | — |
| Oct 4, 2024 | McCall Patrick Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +25,316 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about IN8bio Inc.
Who is the CEO of IN8bio Inc.?
William Tai-Wei Ho is IN8bio Inc.'s President and CEO.
How many directors are on IN8bio Inc.'s board?
IN8bio Inc.'s board has 8 directors: Alan S. Roemer, Corinne Epperly, Emily Fairbairn, Jeremy R. Graff, Luba Greenwood, Peter C. Brandt, Travis Whitfill and William Tai-Wei Ho.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="in8bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.